Center for Applied Biomedical Research, Bologna, Italy
Reports from Italy, Spain and the New Zealand describe recent advances in obesity research
Published in Fitness and Wellness Business Week, June 28th, 2006
Study 1: Review discusses endocannabinoids and the cannabinoid type 1 receptor (CB1) in the control of energy balance.
According to a recent review from Italy, "The promising results obtained by clinical trials using Rimonabant to tackle visceral obesity and related disorders recently promoted a remarkable impulse to carry out detailed investigations into the mechanisms of action of endocannabinoids in regulating food intake and energy metabolism. The endocannabinoid system has been known for many years to play an important role in the modulation of the neuronal pathways...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Fitness and Wellness Business Week
More Articles from Fitness and Wellness Business Week
- Antares Pharma, Inc.
Antares Pharma, Eli Lilly file joint patent application for needle-free injection device - Atherotech, Inc.
VAP cholesterol test uncovers polycystic ovarian syndrome - Cytori Therapeutics, Inc.
First three patients treated in clinical safety and feasibility study for breast reconstruction - Genentech, Inc.
Autologous hematopoietic cell transplant mortality is not linked to BMI in lymphoma patients - Centers for Excellence in Laparoscopic Obesity Surgery, Las Vegas, U.S.
Reports from the United States add new data to obesity research - Children's Hospital of Philadelphia
Obese mothers' concern about infant overeating is linked to offspring adiposity at 5 years - More from this issue of Fitness and Wellness Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
